{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:32:37Z","timestamp":1793302357907,"version":"4.5.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The m7G methyltransferase METTL1 has been implicated in the occurrence and progression of several cancers. However, its clinical significance in cutaneous melanoma (SKCM) remains poorly understood. To address this gap, we conducted comprehensive data mining using publicly available datasets and two single-cell datasets. Additionally, we employed CCK8 assays, clone formation assays, and cell migration and invasion experiments to validate our findings from the data mining. Our results revealed that METTL1 is significantly upregulated in SKCM and is associated with a stem cell-like phenotype. Patients with high METTL1 expression exhibited worse prognosis. Furthermore, we identified that the high expression of METTL1 in SKCM is driven by copy number amplification and regulated by the transcription factor MYC. <jats:italic>In vitro<\/jats:italic> cellular studies confirmed that METTL1 knockdown significantly inhibited SKCM cell proliferation, clone formation, migration, and invasion. Notably, we observed a strong negative correlation between METTL1 expression and CD8+ T-cell infiltration in SKCM tissues. Moreover, our analysis revealed a significant negative correlation between METTL1 expression levels and the response to immunotherapy in SKCM patients, suggesting that METTL1 may serve as a potential biomarker for predicting immunotherapy response in SKCM. In summary, this study enhances our understanding of the role of m7G RNA modification in tumor progression and highlights METTL1 as a novel therapeutic target and biomarker for SKCM immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1575219","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:29:10Z","timestamp":1747286950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Upregulated m7G methyltransferase METTL1 is a potential biomarker and tumor promoter in skin cutaneous melanoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Luling","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.omto.2022.05.009","article-title":"Novel roles of METTL1\/WDR4 in tumor via m(7)G methylation","volume":"26","author":"Cheng","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","article-title":"Methyltransferase-like proteins in cancer biology and potential therapeutic targeting","volume":"16","author":"Qi","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B3","article-title":"N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancer","volume":"13","author":"Cai","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-022-01285-5","article-title":"The potential role of N(7)-methylguanosine (m7G) in cancer","volume":"15","author":"Luo","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.90382","article-title":"M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets","volume":"20","author":"Han","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"216165","DOI":"10.1016\/j.canlet.2023.216165","article-title":"When N(7)-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities","volume":"562","author":"Du","year":"2023","journal-title":"Cancer Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.v11.12","article-title":"METTL1-m(7) G-EGFR\/EFEMP1 axis promotes the bladder cancer development","volume":"11","author":"Ying","year":"2021","journal-title":"Clin Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-023-01809-8","article-title":"METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer","volume":"22","author":"Garcia-Vilchez","year":"2023","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","article-title":"METTL1-mediated m(7)G modification of Arg-TCT tRNA drives oncogenic transformation","volume":"81","author":"Orellana","year":"2021","journal-title":"Mol Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41467-022-29125-7","article-title":"N(7)-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR\/ULK1\/autophagy axis","volume":"13","author":"Han","year":"2022","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01235-4","article-title":"Tumor aneuploidy predicts survival following immunotherapy across multiple cancers","volume":"54","author":"Spurr","year":"2022","journal-title":"Nat Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02275-1","article-title":"RNA modifications in cancer","volume":"129","author":"Tang","year":"2023","journal-title":"Br J Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-023-00645-2","article-title":"RNA modifications in physiology and disease: towards clinical applications","volume":"25","author":"Delaunay","year":"2024","journal-title":"Nat Rev Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"110650","DOI":"10.1016\/j.cellsig.2023.110650","article-title":"Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjogren\u2019s syndrome","volume":"106","author":"Liu","year":"2023","journal-title":"Cell Signal"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.cell.2023.05.047","article-title":"QKI shuttles internal m(7)G-modified transcripts into stress granules and modulates mRNA metabolism","volume":"186","author":"Zhao","year":"2023","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","article-title":"METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-019-01830-9","article-title":"METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN","volume":"97","author":"Tian","year":"2019","journal-title":"J Mol Med (Berl)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.08.005","article-title":"METTL1\/WDR4-mediated m(7)G tRNA modifications and m(7)G codon usage promote mRNA translation and lung cancer progression","volume":"29","author":"Ma","year":"2021","journal-title":"Mol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.molcel.2018.06.001","article-title":"Mettl1\/Wdr4-Mediated m(7)G tRNA Methylome Is Required for Normal mRNA Translation and Embryonic Stem Cell Self-Renewal and Differentiation","volume":"71","author":"Lin","year":"2018","journal-title":"Mol Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12015-022-10444-7","article-title":"METTLing in stem cell and cancer biology","volume":"19","author":"Tooley","year":"2023","journal-title":"Stem Cell Rev Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13287-020-01814-4","article-title":"METTL1-mediated m(7)G methylation maintains pluripotency in human stem cells and limits mesoderm differentiation and vascular development","volume":"11","author":"Deng","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327230","article-title":"Targeting tumour-intrinsic N(7)-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32585","article-title":"Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2023","journal-title":"Hepatology"},{"key":"B25","article-title":"N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma","volume":"13","author":"Xu","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.795240","article-title":"A comprehensive analysis of METTL1 to immunity and stemness in pan-cancer","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1186\/s12967-024-05991-1","article-title":"METTL1 mediates PKM m7G modification to regulate CD155 expression and promote immune evasion in colorectal cancer","volume":"22","author":"Wang","year":"2024","journal-title":"J Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1575219\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:29:11Z","timestamp":1747286951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1575219\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2025.1575219"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1575219","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"1575219"}}